Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Getting Ahead of What Comes Next |Natalie Sandman,General Partner,Spark Capital
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Natalie Sandman is the General Partner, Early at Spark Capital.
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Farid Basir, Chief Human Capital Officer at Telekom Malaysia, will speak at Asia's largest HR and Work Tech Conference in February.
00:10:00
Exploring Beyond Callek: Beowulf's Diverse Ventures and Ongoing Progress
00:10:00
"Insights and Updates: Javier Sáenz de Cenzano Discusses Fund Performance and Interviews New Manager Pavel Begun of 3G Capital"
00:10:00
SUPERIOR SAFETY PROFILE WITH MINIMAL SIDE EFFECTS|JOHN CAVAN,CEO,ContraVir Pharmaceuticals Inc
00:10:00
5 Strategies to Reduce Taxes in Retirement
00:10:00
Interview with Massimo Mauri, CEO of SECO.
00:10:00
passionate entrepreneurs aspiring to transform the business|Michael Greeley,Co-Founder and General Partner,Flare Capital Partners
00:10:00
Building A Startup In The B2B Payments Space|Amy Zaghloul,Director, Canada,Antler
00:10:00
Shahar Bar, SVP of Video Products & Corporate Development at Harmonic Inc., discusses competition in the media industry.
00:10:00
Robert LoCascio, CEO of LivePerson, revealed a business strategy secret during his Mobile World Congress interview.
00:10:00
Index covers every investment stage, from earliest seed through to explosive growth|Rex Woodbury,Partner,Index Ventures
00:10:00
John Inch of Gordon Haskett provides in-depth insights on market trends and investment strategies in this full interview.